Importantly, anti-TLR9-treated Unc93b1+/3dPld3−/−Pld4−/− mice showed a clinical benefit even though the disease was already severe prior to treatment, indicating that TLR9 blockade might be beneficial long after HLH disease initiation. Here, TLR9 is linked to hemophagocytic syndrome.